Anastasiia Kotaieva Sells 55,604 Shares of Nukkleus (NASDAQ:NUKK) Stock

Nukkleus Inc. (NASDAQ:NUKK) insider Anastasiia Kotaieva sold 55,604 shares of the business’s stock in a transaction dated Friday, December 26th. The shares were sold at an average price of $4.26, for a total value of $236,873.04. Following the completion of the transaction, the insider directly owned 1,149,989 shares in the company, valued at $4,898,953.14. This represents a 4.61% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Anastasiia Kotaieva also recently made the following trade(s):

• On Monday, December 29th, Anastasiia Kotaieva sold 75,000 shares of Nukkleus stock. The stock was sold at an average price of $4.09, for a total value of $306,750.00.
• On Wednesday, December 24th, Anastasiia Kotaieva sold 55,604 shares of Nukkleus stock. The stock was sold at an average price of $4.49, for a total value of $249,661.96.
• On Tuesday, December 23rd, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The shares were sold at an average price of $4.57, for a total value of $319,900.00.
• On Monday, December 22nd, Anastasiia Kotaieva sold 30,000 shares of Nukkleus stock. The stock was sold at an average price of $4.41, for a total value of $132,300.00.
• On Friday, December 19th, Anastasiia Kotaieva sold 70,000 shares of Nukkleus stock. The stock was sold at an average price of $4.53, for a total transaction of $317,100.00.
• On Thursday, December 18th, Anastasiia Kotaieva sold 38,744 shares of Nukkleus stock. The shares were sold at an average price of $4.72, for a total transaction of $182,871.68.

Nukkleus Price Performance

Nukkleus stock opened at $4.03 on Friday. The company has a market capitalization of $67.10 million, a PE ratio of 0.25 and a beta of -6.66. Nukkleus Inc. has a 12-month low of $3.31 and a 12-month high of $40.98. The firm’s fifty day moving average is $5.53 and its 200 day moving average is $6.75.

Key Nukkleus News

Here are the key news stories impacting Nukkleus this week:

• Positive Sentiment: Nukkleus completed the acquisition of Israeli defense-software firm Tiltan, adding ~30 years of defense AI expertise and established vendor relationships (IAI, Elbit, Rafael). This expands Nukkleus’s product set and creates a pathway to defense-market revenue. Nukkleus Completes Tiltan Acquisition
• Neutral Sentiment: Major outlets (MSN, TipRanks) circulated the acquisition news, increasing visibility; however, the announcements lack financial detail (purchase price, projected revenue, integration plan), so near‑term earnings impact is uncertain. TipRanks Announcement
• Negative Sentiment: Insider selling: director/officer Anastasiia Kotaieva sold several large blocks across Dec. 18–29 totaling roughly 286,208 shares for about $1.25M in proceeds (sales at ~$4.09–$4.72). Concentrated insider disposals can create selling pressure and be interpreted negatively by investors. SEC Filing (Insider Sales)

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on NUKK. Weiss Ratings reissued a “sell (d+)” rating on shares of Nukkleus in a research report on Wednesday, December 24th. Wall Street Zen upgraded Nukkleus from a “sell” rating to a “hold” rating in a report on Sunday, November 23rd. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the business. BNP Paribas Financial Markets bought a new stake in shares of Nukkleus during the second quarter worth about $56,000. Ausdal Financial Partners Inc. acquired a new position in Nukkleus during the 3rd quarter valued at about $105,000. Finally, UBS Group AG boosted its stake in Nukkleus by 23.3% during the 3rd quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after purchasing an additional 15,223 shares during the last quarter. 12.47% of the stock is currently owned by institutional investors and hedge funds.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.